Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Cognitive Impairment Has a Strong Relation to Nonsomatic Symptoms of Depression in Relapsing-Remitting Multiple Sclerosis.
Symptoms, Prevalence and Impact of Multiple Sclerosis in Younger Patients: A Multinational Survey.
Prediction of response to interferon therapy in multiple sclerosis.
Retinal Axonal Loss Begins Early in the Course of Multiple Sclerosis and Is Similar between Progressive Phenotypes.
Evaluation of olfactory dysfunction in neurodegenerative diseases.
Magnetic Resonance Spectroscopy to Assess NeuroInflammation and Neuropathic Pain.
Cannabinoids in the management of difficult to treat pain.
JCV test stratifies PML risk in antibody-positive MS
Transplantation of umbilical cord and bone marrow-derived mesenchymal stem cells in a patient with relapsing-remitting multiple sclerosis.
A case of multiple sclerosis improvement following removal of heavy metal intoxication : Lessons learnt from Matteo's case.
Patient's Perspective: Hard Lessons from a Long Hospital Stay.
Value of susceptibility-weighted imaging in acute hemorrhagic leukoencephalitis.
Lack of response to pulse cyclophosphamide in neuromyelitis optica: evaluation of 7 patients.
Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration.
Previous treatment influences fingolimod efficacy in relapsing-remitting multiple sclerosis: results from an observational study.
At Four Years, Treatment Effect Maintained in More Than Two-Thirds of Patients Who Received Genzyme’s Lemtrada in Pivotal Studies
Hyperconnectivity is a Fundamental Response to Neurological Disruption.
Pathology and disease mechanisms in different stages of multiple sclerosis.
Control of experimental autoimmune encephalomyelitis by T cells responding to activated T cells.
Synthesis of 5α-cholestan-6-one derivatives and their inhibitory activities of NO production in activated microglia: Discovery of a novel neuroinflammation inhibitor.
Low-contrast multifocal visual evoked potentials: Identifying more shades of gray in MS.
Cost-sharing and initiation of disease-modifying therapy for multiple sclerosis.
Motor vehicle operation in the setting of multiple sclerosis with myelopathy: assessment, adaptive equipment, counseling, and cessation of driving.
Mortality in multiple sclerosis: meta-analysis of standardised mortality ratios.
Structure, Size, and Solubility of Antigen Arrays Determines Efficacy in Experimental Autoimmune Encephalomyelitis.

Pages